Table 2. Demographic and clinical characteristics of patient cases in the adjuvant and salvage setting.
| Adjuvant | Salvage | |
|---|---|---|
| No. (N=12) (%) | No. (N=12) (%) | |
| Age (Years at RP or at BCR) | ||
| Median (Min, Max) | 60 (48, 70) | 66 (57, 74) |
| Pre-operative Prostate-specific Antigen | ||
| <10 ng/mL | 10 (83.3) | 9 (75) |
| 10-20 ng/mL | 1 (8.3) | 2 (16.7) |
| >20 ng/mL | 1 (8.3) | 0 |
| NA | 0 | 1 (8.3) |
| D'Amico risk groups | ||
| Low | 2 (16.7) | 1 (8.3) |
| Intermediate | 4 (33.3) | 7 (58.3) |
| High | 6 (50) | 4 (33.3) |
| Pathological Stage | ||
| pT2N0M0 | 6 (50) | 8 (66.7) |
| pT3N0M0 | 6 (50) | 4 (33.3) |
| Extracapsular Extension | ||
| Present | 5 (41.7) | 3 (25) |
| Seminal Vesicle Invasion | ||
| Present | 4 (33.3) | 2 (16.7) |
| Surgical Margin Status | ||
| Positive | 8 (66.7) | 6 (50) |
| Pathological Gleason Score | ||
| 6 | 3 (25) | 0 |
| 7 (3+4) | 4 (33.3) | 2 (16.7) |
| 7 (4+3) | 1 (8.3) | 4 (33.3) |
| 8 | 1 (8.3) | 5 (41.7) |
| 9 | 2 (16.7) | 1 (8.3) |
| 10 | 1 (8.3) | 0 |
| Time to BCR (months) | ||
| Median (Min, Max) | NA | 16 (1, 112) |
| ≤36 months | NA | 9 (75) |
| >36 months | NA | 3 (25) |
| PSAdt | ||
| <6 months | NA | 5 (41.7) |
| ≥6 months | NA | 6 (50) |
| <9 months | NA | 9 (75) |
| ≥9 months | NA | 2 (16.7) |
| NA | NA | 1 (8.3) |
Abbreviations: RP, radical prostatectomy; BCR, biochemical recurrence; PSAdt: PSA doubling time